Listed

Sunshine Biopharma Inc.: Form 10-Q for the period ended Sep 30, 2014

Filed with the SEC on Nov 12, 2014 and accepted by EDGAR at Nov 12, 2014, 07:00 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-07-01 to 2014-09-30$0us-gaap:SalesRevenueGoodsNet
Revenue9 months2014-01-01 to 2014-09-30$0us-gaap:SalesRevenueGoodsNet
Research and development9 months2014-01-01 to 2014-09-30$323.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-07-01 to 2014-09-30−$277.4kus-gaap:OperatingIncomeLoss
Operating income9 months2014-01-01 to 2014-09-30−$1.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-07-01 to 2014-09-30$3.4kus-gaap:InterestExpense
Interest expense9 months2014-01-01 to 2014-09-30$151.7kus-gaap:InterestExpense
Net income3 months2014-07-01 to 2014-09-30−$280.8kus-gaap:NetIncomeLoss
Net income9 months2014-01-01 to 2014-09-30−$1.6mus-gaap:NetIncomeLoss
Basic EPS3 months2014-07-01 to 2014-09-30$0.00us-gaap:EarningsPerShareBasic
Basic EPS9 months2014-01-01 to 2014-09-30−$0.02us-gaap:EarningsPerShareBasic
Operating cash flow9 months2014-01-01 to 2014-09-30−$350.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2014-09-30$173.9kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-09-30$180.3kus-gaap:AssetsCurrent
Total assetsAt period end2014-09-30$180.3kus-gaap:Assets
Total liabilitiesAt period end2014-09-30$456.6kus-gaap:Liabilities
Shareholders' equityAt period end2014-09-30−$276.4kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-14-005565. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.